
Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis1
Author(s) -
Pedro Joya-Vazquez,
Forrest Dodson,
Igor Dvorchik,
Edward A. Gray,
Amy Chesky,
Anthony J. Demetris,
Obaid Shakil,
John J. Fung,
Hugo E. Vargas
Publication year - 2002
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-200205270-00013
Subject(s) - medicine , cirrhosis , hepatitis b virus , serology , gastroenterology , liver transplantation , transplantation , hepatitis b , hepatitis , antibody , immunology , surgery , virus
The present scarcity of organ donors requires consideration of grafts from sources not previously used. Several studies have addressed the use of grafts from donors who have antibodies to the hepatitis B core antigen (anti-HBc+). The aim of this study was to evaluate the impact of the use of anti-HBc+ grafts in patients transplanted for hepatitis B virus (HBV)-related cirrhosis.